Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

646

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Multiple Sclerosis
Interventions
DRUG

fampridine

DRUG

Placebo

Matched placebo

Trial Locations (87)

1113

Research site, Sofia

1142

Research site, Sofia

1407

Research Site, Sofia

1431

Research site, Sofia

1606

Research site, Sofia

1797

Research Site, Sofia

4002

Research site, Plovdiv

4818

Research Site, Breda

5223

Research Site, 's-Hertogenbosch

5800

Research site, Pleven

6162

Research Site, Sittard-Geleen

11000

Research site, Belgrade

12808

Research site, Prague

14642

Research site, Rochester

15006

Research site, Prague

18000

Research site, Niš

20133

Research site, Milan

20520

Research site, Turku

24018

Research site, Roanoke

28207

Research site, Charlotte

28210

Research site, Charlotte

32806

Research Site, Orlando

33407

Research site, West Palm Beach

33520

Research site, Tampere

33612

Research site, Tampa

33634

Research site, Tampa

34000

Research site, Kragujevac

34205

Research site, Bradenton

35055

Research site, Rzeszów

35058

Research site, Cullman

40513

Research site, Lexington

41501

Research site, Teplice

43210

Research site, Columbus

48201

Research site, Detroit

50009

Research site, Kaunas

53203

Research site, Pardubice

56501

Research site, Choceň

58633

Research site, Jihlava

60155

Research Site, Nizhny Novgorod

62064

Research site, Plewiska

62500

Research site, Brno

63017

Research site, Chesterfield

65691

Research site, Brno

73601

Research site, Havířov

80138

Research site, Napoli

85013

Research site, Phoenix

90220

Research site, Oulu

92108

Research site, San Diego

92288

Research site, Klaipėda

98121

Research site, Messina

127015

Research Site, Moscow

129128

Research site, Moscow

420021

Research Site, Kazan'

650066

Research site, Kemerovo

660037

Research site, Krasnoyarsk

02740

Research site, New Bedford

00100

Research site, Helsinki

Unknown

Research Site, Gallarate

00189

Research site, Rome

08661

Research site, Vilnius

15-276

Research Site, Bialystok

80-803

Research site, Gdansk

86-300

Research site, Grudziądz

40-595

Research Site, Katowice

40-749

Research Site, Katowice

40-752

Research site, Katowice

25-726

Research Site, Kielce

31-505

Research site, Krakow

31-637

Research site, Krakow

90-324

Research site, Lodz

10-561

Research site, Olsztyn

00-669

Research site, Warsaw

01-697

Research site, Warsaw

04-749

Research site, Warsaw

EX2 5DW

Research site, Exeter

PL6 8DH

Research site, Plymouth

RM7 0AG

Research site, Romford

M6 8HD

Research site, Salford

NR4 7UY

Research site, Norwich

G51 4TF

Research site, Glasgow

KT16 0PZ

Research site, Chertsey

SA6 6NL

Research site, Cardiff

B15 2WB

Research site, Birmingham

E1 2AT

Research site, London

NW3 2QG

Research site, London

WC1N 3BG

Research site, London

NG7 2UH

Research site, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY